Rule 425 Communication · 425
SYNLOGIC INC
Rule 425 Communication
Company context
Synlogic is a biopharmaceutical company historically focused on advancing novel therapeutics to transform the care of serious disease in need of new treatment options.
Current securities
Recent company filings
- 10-Q filingAug 11, 2026
- SCHEDULE 13D/A - filed by New Enterprise Associates 14, L.P. regarding SYNLOGIC, INC.Jul 29, 2026
- SCHEDULE 13D/A - filed by Funicular Funds, LP regarding SYNLOGIC, INC.Jul 29, 2026
- Entry into a Material Definitive Agreement · Material Modification to Rights of Security Holders · Changes in Control of Registrant · Regulation FD DisclosureJul 29, 2026
- 10-Q filingMay 14, 2026
As-filed source
As filedOpen full document ↗